AGM/EGMApr 30, 2026, 05:23 PM
SNDX to Hold 2026 Annual Meeting on June 10; Key Proposals
AI Summary
Syndax Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026. Stockholders will vote on the election of two Class I directors, an advisory resolution on executive compensation, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm. Additionally, stockholders will consider the approval of the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan.
Key Highlights
- Annual Meeting to be held virtually on June 10, 2026, at 12:00 p.m. EDT.
- Stockholders of record as of April 21, 2026, are eligible to vote.
- Proposals include election of two Class I directors: Pierre Legault and Michael A. Metzger.
- Advisory vote on named executive officer compensation.
- Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
- Approval of the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan.
- Approval of the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan.
Price Impact
More from SNDX